The approved
forms must contain the following: 1) expiration date, 2) OMB
control number, and 3) PRA burden statement.
Inventory as of this Action
Requested
Previously Approved
05/31/2018
36 Months From Approved
5,200
0
0
5,600
0
0
0
0
0
Decision Memorandum CAG#-00438N
entitled Transcatheter Mitral Valve Repair (TMVR) for Degenerative
Mitral Regurgitation was published August 7, 2014. In this
decision, CMS determined that it the evidence is sufficient to
cover TMVR under Coverage with Evidence Development for Medicare
beneficiaries under certain conditions only when the provider is
participating in and patients are enrolled in a qualifying clinical
studies meeting certain requirements. Consistent with section 1142
of the Social Security Act, the Agency for Healthcare Research and
Quality (AHRQ) supports clinical research studies that the CMS
determines meet specified standards and address the specified
research questions.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.